documents: FDA-2011-D-0611-0094
Data license: Public Domain (U.S. Government data) · Data source: U.S. government sources, plus a few identifier registries; each is listed on the methodology page
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2011-D-0611-0094 | FDA | FDA-2011-D-0611 | New and Revised Draft Q&As on Biosimilar Development and the BPCI Act (Revision 4) Guidance for Industry - Draft Guidance | Other | Guidance | 2026-03-10T04:00:00Z | 2026 | 3 | 2026-03-10T04:00:00Z | 2026-05-12T03:59:59Z | 2026-05-12T09:00:11Z | 1 | 0 | 09000064b92071bb |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref